PEX7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.228800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.415600E-01
Normal-vs-Stage2
5.593400E-01
Normal-vs-Stage3
3.772800E-01
Normal-vs-Stage4
7.786000E-02
Stage1-vs-Stage2
2.595600E-01
Stage1-vs-Stage3
7.934200E-02
Stage1-vs-Stage4
8.801800E-01
Stage2-vs-Stage3
1.646960E-01
Stage2-vs-Stage4
2.504000E-01
Stage3-vs-Stage4
2.324800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.200400E-01
Normal-vs-AfricanAmerican
3.125400E-01
Normal-vs-Asian
7.318000E-01
Caucasian-vs-AfricanAmerican
8.240800E-01
Caucasian-vs-Asian
5.995400E-01
AfricanAmerican-vs-Asian
5.727200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.354000E-01
Normal-vs-Female
5.125600E-01
Male-vs-Female
3.816800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.544800E-01
Normal-vs-Age(41-60Yrs)
5.021800E-01
Normal-vs-Age(61-80Yrs)
5.664800E-01
Normal-vs-Age(81-100Yrs)
3.835600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.506600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.879000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.496200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.216800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.672400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.557400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.476000E-01
Normal-vs-Daily Drinker
7.091200E-01
Normal-vs-Weekly Drinker
6.351800E-01
Normal-vs-Occasional Drinker
3.788400E-01
Normal-vs-Social Drinker
5.909800E-01
Non Drinker-vs-Daily Drinker
7.924000E-01
Non Drinker-vs-Weekly Drinker
6.286000E-01
Non Drinker-vs-Occasional Drinker
9.048300E-02
Non Drinker-vs-Social Drinker
6.582200E-01
Daily Drinker-vs-Weekly Drinker
5.394000E-01
Daily Drinker-vs-Occasional Drinker
7.501800E-02
Daily Drinker-vs-Social Drinker
5.288600E-01
Weekly Drinker-vs-Occasional Drinker
2.728600E-01
Weekly Drinker-vs-Social Drinker
8.634000E-01
Occasional Drinker-vs-Social Drinker
1.618580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.976970E-01
Normal-vs-Grade 2
5.730100E-02
Normal-vs-Grade 3
4.266100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.495800E-01
Grade 1-vs-Grade 3
1.848040E-01
Grade 1-vs-Grade 4
1.976970E-01
Grade 2-vs-Grade 3
8.477800E-01
Grade 2-vs-Grade 4
5.730100E-02
Grade 3-vs-Grade 4
4.266100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.229400E-01
Normal-vs-NonDiabetic
5.461400E-01
Diabetic-vs-NonDiabetic
3.220800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.586000E-01
Normal-vs-NoPancreatitis
5.645800E-01
Pancreatitis-vs-NoPancreatitis
5.998400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.267200E-01
Normal-vs-N1
5.700200E-01
N0-vs-N1
9.168000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.723400E-01
Normal-vs-TP53-NonMutant
2.302800E-01
TP53-Mutant-vs-TP53-NonMutant
1.358800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
